App-Quantinova.ai

Survey on the management of cancer associated thrombosis (CAT) in haemato-oncology patients with thrombocytopenia

H. Okoye - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Targeted panel sequencing for identifying new rare genetic variants associated with venous thromboembolism (VTE): application to 128 patients with unprovoked VTE and negative thrombophilia screening

P. Suchon - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The (T) thrombosis (I) in patients with (L) lower (L) limb (I) injuries (R) requiring (I) immobilisation (TILLIRI) study: A prospective observational multicentre study – Early Results

T. O Halloran - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The ADAMTS-13 / von Willebrand factor (VWF) ratio as a prognostic biomarker for the development of portal vein thrombosis (PVT) in patients with compensated cirrhosis.

R. De Cristofaro - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

The CLUES Study: A Critical Look at Understanding the Emotional Suffering of Blood Clot Survivors

R. Rosovsky - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Incidence and Risk Factors of Venous and Arterial Thrombosis in Ovarian Cancer Patients- Results from a Population Database

A. Lukey - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The increase in plasma cell-free DNA in patients with venous thromboembolism is independent of DNaseI activity

R. Herranz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The increased risk of venous thromboembolism (VTE) in obese pregnant women is due to more prolonged exposure to a procoagulant state.

S. McNeill - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

The Lung Pro-thrombotic Niche Drives Cancer-Associated Thromboembolism via Exosomal ITGB2

S. Lucotti - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Ottawa Score did not predict recurrent venous thromboembolism in the prospective TROPIQUE cohort study

C. Frere - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

The participation of plant heparinoids in the regulation of blood clotting

E. Maystrenko - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

The potentiality of thromboelastographic examination of newborns with venous thrombosis

A. Ilyina - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The predictive value of pulmonary infarction in patients with acute pulmonary embolism on persistent symptoms and adverse events

F. Kaptein - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Prevalence of Thrombophilia in Patients with Cancer Associated Thromboembolism

J. Hirmerov - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The ratio of von Willebrand factor activity to antigen in newly diagnosed essential thrombocythemia

K. Yokoyama - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

folitixorin calcium

The risk of incident venous thromboembolism attributed to overweight and obesity: The Tromsø Study

T. Frischmuth - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The risk of venous thromboembolism after minor surgical procedures: A population-based case-control study

M. Smeets - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The role of anticoagulation in the management of tumour thrombosis: A single centre retrospective study

U. Faruqi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The role of neutrophil extracellular traps (NETs) in lower extremity artery disease (LEAD)-specific thrombosis

M. Thakur - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

The use of plasminogen activator inhibitor-1 specific Affimers as a tool to modulate fibrin clot properties and thrombosis risk

R. Altalhi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts